L-glutamine therapy for sickle cell diseases and thalassemia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 2, 1997
Grant Date -
N/A
app pub date -
May 1, 1996
filing date -
May 1, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method and kit for treating patients suffering from sickle cell disease and thalassemia. The method includes regularly administering a safe and pharmacologically effective amount of L-glutamine based compound to a patient to reduce pain, requirement for pain killers, and increase energy and activity levels.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully